Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 17.1B | 18.3B | 19.6B | 18.3B |
Cost of revenue | 14.0B | 14.4B | 15.9B | 15.1B |
Gross profit | 3.1B | 3.9B | 3.7B | 3.2B |
Operating expense | ||||
Research & development | 695.8M | 704.5M | 740.5M | 668.0M |
Selling general and admin | 445.7M | 452.2M | 407.9M | 494.5M |
Other operating expenses | — | — | — | — |
Operating income | 2.0B | 2.8B | 2.6B | 2.0B |
Non operating interest income | ||||
Income | 96.6M | 79.0M | 73.9M | 111.9M |
Expense | 64.7M | 58.7M | 55.3M | 72.6M |
Other income expense | — | — | — | — |
Pretax income | 2.3B | 2.7B | 2.9B | 2.7B |
Tax provision | 401.5M | 552.2M | 611.5M | 612.7M |
Net income | 1.9B | 2.2B | 2.3B | 2.1B |
Basic EPS | — | 2.3 | 2.5 | 2.3 |
Diluted EPS | — | 2.3 | 2.4 | 2.3 |
Basic average shares | — | 745.7M | 746.2M | 747.3M |
Diluted average shares | — | 749.0M | 749.3M | 750.3M |
EBITDA | 5.6B | 5.8B | 6.2B | 6.1B |
Net income from continuing op. | 2.3B | 2.7B | 2.9B | 2.7B |
Minority interests | -403.8M | -452.0M | -484.9M | -370.1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |